Substance Use Disorders Flashcards
Dopamine reward pathway
Dopamine pathways that form part of the central nervous system (CNS) “reward system” have been identified in the ventral tegmental region of the forebrain and in the nucleus accumbens
All drugs of abuse appear to target the brain’s reward system by ___
All drugs of abuse appear to target the brain’s reward system by flooding the circuit with dopamine
Substances that do not ____ are rarely misused.
Substances that do not provide some form of pleasure or relief are rarely misused.
Symptoms and BAC in individuals without alcohol tolerance
- 0–100 mg/dL: A sense of well-being, sedation, tranquility
- 100–150 mg/dL: Incoordination, irritability
- 150–250 mg/dL: Slurred speech, ataxia
- >250 mg/dL: Passing out, unconsciousness
- Higher concentrations—greater than 350 mg/dL—can lead to coma and death
The presence of few symptoms of alcohol intoxication in an individual with a BAC > ____ is indicative of a likely alcohol use disorder.
The presence of few symptoms of alcohol intoxication in an individual with a BAC > 150 is indicative of a likely alcohol use disorder.
This is an empirical demonstration that this individual has tolerance to alcohol, which is most often acquired from regular use of high doses.
In many jurisdictions, a motor vehicle operator is considered legally under the influence at a blood alcohol concentration of ___
In many jurisdictions, a motor vehicle operator is considered legally under the influence at a blood alcohol concentration of 0.08 g per 100 mL, equivalent to 80 mg/dL
Metabolic changes in individuals with alcohol use disorder
- Elevated LDH
- Decreased BUN (diuretic effect)
- Decreased red cell volume with increased MCV
- Increased uric acid
- On liver tests:
- Increased GGT
- Increased AST/ALT, with AST/ALT ratio > 1 (often >2)
Clinical manfiestations of chronic alcohol use disorder detectable on physical exam
- Acne rosacea (on an adult, not unusual on adolescent)
- Palmar erythema
- Painless hepatomegaly (alcoholic fatty liver disease)
- Unexplained bruises
- Jaundice, ascites, gynecomastia (liver failure signs)
- Dupuytren’s contractures (very advanced AUD)
- Testicular atrophy (males)
- Hx Respiratory (or other) infection, periods of amnesia, or unexplained falls at home, concerns about driving skill or arrest/accident related to driving
What is going on in this individual’s hand?
Dupuytren’s contractures
PNS damage in alcohol use disorder
- Peripheral neuropathy occurs in stocking-and-glove distribution
- Probably the result of alcohol-induced B vitamin deficiencies
Cerebellar damage in alcohol use disorder
Common cause of dysarthria, ataxia, and instability in chronic alcohol use
Wernicke’s encephalopathy
- The syndrome of thiamine deficiency
- May be caused by chronic alcohol use
- Syndrome of nystagmus, ataxia, and mental confusion that may be reversible by supplementation of thiamine
- Wernicke-Korsakoff syndrome is when cognitive and memory impairment persists even after thiamine supplementation. These patients oftel also present with anterograde amnesia and confabulation.
Imaging findings of chronic alcohol use
- Necrotic lesions in mamillary bodies, thalamus, other brainstem lesions
- Enlarged cerebral ventricles and widened cortical sulci
- This appears to be partially reversible when the individual abstains from drinking
Uncomplicated alcohol withdrawal
- Begins 12-18 hrs post-cessation
- Peaks at 24-48 hrs, takes ~1 week to subside
- Minor symptoms include anxiety, tremors, and nausea and vomiting; heart rate and blood pressure may be increased.
Alcoholic withdrawal seizure
- May occur 7-38 hours post-cessation
- Peak risk is 24-48 hours
- The patient may have a single burst of one to six generalized seizures; status epilepticus is rare.
- Withdrawal seizures occur primarily as a consequence of severe, long-term alcohol misuse.
Alcoholic hallucinosis
- Begin within ~48 hrs post-cessation
- Occur in the presence of a clear sensorium
- Vivid and unpleasant auditory, visual, or tactile hallucinations
- The hallucinations typically last about 1 week but can become chronic. Like withdrawal seizures, they are a sign of severe alcohol misus
Alcohol withdrawal delirium
- 5% of individuals hospitalized with AUD
- 1/3 of those with withdrawal seizures
- Symptoms include confusion, agitation, perceptual disturbance, mild fever, and autonomic hyperarousal
- 2-3 days post-cessation, or 4-5 days after a decrease in consumption rate
When interviewing a patient with a diagnosis of AUD, you should always ask. . .
. . . what symptoms they have when they are intoxicated and in withdrawal
Management of alcohol withdrawal
- general support (i.e., adequate food and hydration, careful medical monitoring, electrolytes)
- nutritional supplementation (oral thiamine, folic acid, multivitamin, some may be administered intramuscularly if oral intake not feasible)
- Use of benzodiazepines
Best pharmacologic treatment for symptoms of alcohol withdrawal
Chlordiazepoxide
A benzodiazepine especially good for this use. Benzos are cross-tolerant with alcohol, and are one of the only other depressants that can be used for this indication.
Intermediate- or short-acting benzodiazepines (e.g., lorazepam, oxazepam) are generally preferred in patients with liver damage or in elderly patients because these benzodiazepines lack metabolites and are renally excreted
Drugs approved for treating chronic alcohol use disorder (not acute toxicosis/withdrawal)
- Disulfiram: Inhibits aldehyde dehydrogenase, an enzyme necessary for the metabolism of alcohol. Inhibiting this enzyme leads to the accumulation of acetaldehyde when alcohol is consumed. Acetaldehyde is toxic and induces noxious symptoms, such as nausea, vomiting, palpitations, and hypotension. Disulfiram should be prescribed only after careful consideration and with the full cooperation of the patient.
- Naltrexone: μ-opioid antagonist that appears to reduce the pleasurable effects of alcohol. The drug is generally well tolerated but can produce nausea, headache, anxiety, or sedation. Unfortunately, it cannot be given to patients with severe liver disease.
- Acamprosate: Glutamate receptor modulator, also reduces craving. Acamprosate is generally well tolerated, although some patients report headache, diarrhea, flatulence, and nausea. Needs to be taken 3x/day.
___ is first-line for psychotic symptoms of alcoholic hallucinosis
Haloperidol or second generation antipsychotic is first-line for psychotic symptoms of alcoholic hallucinosis